DuPont rated Buy for growth in healthcare, water, EV, and aerospace with strong margins and dividend yield.

DuPont is rated a Buy due to its secular growth opportunities and margin expansion potential, driven by strong positions in healthcare, water technologies, electric vehicle (EV) battery adhesives, and aerospace markets. The company benefits from resilient recurring revenues in medical devices and semiconductor water treatment, alongside growth initiatives and productivity programs in diversified industrials. Trading below historical and sector valuation multiples, DuPont targets 8–10% earnings per share growth and offers a 1.82% dividend yield, presenting an attractive risk-reward profile for investors.

DuPont shares trade at USD 131.18 on Pluang as of Sep 25, 2026 01:31 WIB, showing a modest 0.20% gain over the past day. The stock's dividend yield on Pluang stands at 1.83%, closely matching the article's stated 1.82%. Investors on Pluang hold DuPont for an average of 88 days, reflecting steady interest in the company's growth and margin expansion prospects.